The Good and Bad of Those Ubiquitous Drug Ads

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new Kaiser Family Foundation survey.

All previous columns by Drew Altman are available online.